2024
|
Invention
|
Animal models of postnatal conditions associated with reduced levels of plasmalogen. The inventio... |
2020
|
Invention
|
Methods for diagnosing a colorectal cancer (crc) health state or change in crc health state, or f... |
|
Invention
|
Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis.... |
2019
|
Invention
|
Long chain dicarboxylic fatty acid (lcdfa) producing microbes and uses thereof.
A method for inc... |
|
Invention
|
Long chain dicarboxylic fatty acid (lcdfa) producing microbes and uses thereof. BlautiaFaecalibac... |
2018
|
Invention
|
Dicarboxylic fatty acid dimers, and derivatives thereof, as standards for quantifying levels in b... |
|
Invention
|
Cyclic plasmenylethanolamines. 2 are each, independently, a saturated, unsaturated, or polyunsatu... |
|
Invention
|
Cyclic plasmenylethanolamines. Provided herein are cyclic plasmenylethanolamines and plasmalogen ... |
2016
|
Invention
|
Method of lowering cholesterol. The present invention relates to the method of lowering cholester... |
|
Invention
|
Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health state... |
|
Invention
|
Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of agin... |
2015
|
Invention
|
Method for the treatment of senile dementia of the alzheimer's type. The present invention relate... |
|
Invention
|
Method for lowering cholesterol.
The present invention relates to the diagnosis, risk assessment... |
2013
|
Invention
|
Biomarkers useful for diagnosing prostate cancer, and methods thereof.
The present invention des... |
2012
|
Invention
|
Methods for the synthesis of 13c labeled dha and use as a reference standard.
A method for prepa... |
|
Invention
|
Methods for the synthesis of 13c labeled plasmalogen. 13C labeled plasmalogens as represented by ... |
|
Invention
|
Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard. 13C label... |
|
Invention
|
Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses there... |
|
Invention
|
Methods for the diagnosis of dementia and other neurological disorders.
The present invention is... |
|
Invention
|
Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders.
Methods... |
|
Invention
|
Method for lowering cholesterol. The present invention relates to a method of lowering cholestero... |
|
Invention
|
Method for the synthesis of dha.
A method for preparing docosahexaenoic acid (DHA). The method c... |
2010
|
Invention
|
Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis.
A compound of... |
2009
|
Invention
|
Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating d... |
2008
|
Invention
|
Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders. Methods ... |
2007
|
Invention
|
Methods for the treatment of senile dementia of the alzheimer's type. The present invention relat... |
|
Invention
|
Biomarkers for diagnosing multiple sclerosis, and methods thereof.
The present invention describ... |
|
Invention
|
Biomarkers useful for diagnosing prostate cancer, and methods thereof. The present invention desc... |
|
Invention
|
Methods for the diagnosis of dementia and other neurological disorders. The present invention is ... |
2006
|
Invention
|
Method and apparatus for fourier transform ion cyclotron resonance mass spectrometry.
A novel me... |
|
Invention
|
Methods for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e... |
2003
|
Invention
|
Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotro... |